\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 17, 2009 8:00 AM EST \n\n \n Rexahn Pharmaceuticals Provides Third Quarter 2009 Business Update - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 17, 2009 7:02 AM EST \n\n \n BenchmarkJournal.com Receives Analysis on TRMB, TFSL, TEVA, DRIV, UNTD and AMMD - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 10, 2009 4:17 PM EST \n\n \n Teva Receives Final Approval for Generic Prevacid(R) Delayed-Release Capsules - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 10, 2009 9:46 AM EST \n\n \n Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 10, 2009 9:35 AM EST \n\n \n Market Watch: Sunwin International Neutraceuticals - November 10, 2009 - Marketwire\n \n \n | \n\n \n\n \n\n \n\n Nov 10, 2009 2:01 AM EST \n\n \n Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE(R)-Related Patents - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 09, 2009 4:05 PM EST \n\n \n Antares Pharma Reports Third Quarter 2009 Financial and Operating Results - Business Wire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");